EPO and malaria: A number of adjunctive therapies (including nitric oxide, arginine, erythropoietin, levamisole) have demonstrated encouraging results in experimental models of cerebral malaria or in clinical trials in uncomplicated malaria and are awaiting evaluation in severe malaria [11].